At the least, the new 7.2mg results point to scope for hiking the semaglutide dose in CagriSema to chase down that weight-loss target. The company is also running a phase 3b trial of 7.2mg ...

Tirzepatide is the active ingredient in Zepbound, approved by the Food and Drug Administration (FDA) specifically for weight loss. Semaglutide was initially approved under the brand name Ozempic ...

Men, especially, were less likely to agree with medical necessity and more likely to stress the role of personal ...

weight change from baseline for NPM-139 (semaglutide) corrected to control (sham implant). Values are mean ± SE. Weight difference versus control group in healthy Sprague-Dawley Rats.

1 Multiple trials, including hundreds of obese/overweight women in the menopausal/postmenopausal age group, reflect weight loss of at least 5% with three months of semaglutide treatment.

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

You can use Wegovy (semaglutide) as long as you need for weight loss and weight management. You can continue taking Wegovy if you and your doctor determine that Wegovy is safe for you and you can ...

Patients who received preoperative semaglutide had lower postoperative total weight loss at 12 months compared with controls. Median HbA1c levels and diabetes remission at 1 year were similar ...

Semaglutide medications like Ozempic and Wegovy have exploded in popularity in recent years due to their effectiveness in diabetes control and weight loss. Research has revealed additional ...

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is joining the fight.